Insight Into Quality Requirements & Regional Regulatory Variability Impacting Radioligand Therapy (RLT) & Radioligand imaging (RLI) Products from Clinical to Commercial Phase

  • Differentiating kit for radiopharmaceutical preparation from ready to use solutions for injection/infusion
  • Overview of guidelines to be followed for dossier preparation
  • Control strategy, where to start? Control of chemical and radioactive precursors
  • Building up the information/data for submission from clinical to commercial stages